Simplex Trading
JUNO

Simplex Trading’s Juno Therapeutics, Inc. JUNO Stock Holding History

Simplex Trading’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-561
Closed -$246K – 7448
2017
Q4 		$246K Sell
561
-86
-13% -$4.29K 0.01% 1136
2017
Q3 		$57K Buy
647
+75
+13% +$2.56K ﹤0.01% 2196
2017
Q2 		$38K Buy
572
+152
+36% +$3.75K ﹤0.01% 2659
2017
Q1 		$106K Sell
420
-20
-5% -$429 ﹤0.01% 1703
2016
Q4 		$282K Sell
440
-118
-21% -$2.89K 0.02% 838
2016
Q3 		$146K Buy
558
+118
+27% +$3.67K 0.01% 1265
2016
Q2 		$203K Buy
440
+298
+210% +$12.4K 0.01% 984
2016
Q1 		$51K Buy
142
+20
+16% +$697 ﹤0.01% 1947
2015
Q4 		$125K Sell
122
-60
-33% -$2.98K 0.01% 1195
2015
Q3 		$98K Sell
182
-554
-75% -$24.3K 0.01% 1438
2015
Q2 		$310K Buy
736
+613
+498% +$32.5K 0.03% 569
2015
Q1 		$96K Buy
+123
New +$5.97K 0.01% 1123

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Simplex Trading's JUNO Position: Q1 2018 in Review

Simplex Trading sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 16,285 shares — an estimated $744K sold.

Simplex Trading first reported a position in JUNO in Q2 2015 and held it in 7 quarters. The position peaked at $1.19M in Q2 2016. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Simplex Trading reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Simplex Trading sold 16,285 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $744K.
  • Simplex Trading first reported a position in Juno Therapeutics, Inc. in Q2 2015 and held it in 7 quarters.
  • Simplex Trading's Juno Therapeutics, Inc. position peaked at $1.19M in Q2 2016.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Simplex Trading's 13F filing for Q1 2018, filed 26 Apr 2018.